Autoinflammatory and autoimmune conditions at the crossroad of COVID-19
Tóm tắt
Từ khóa
Tài liệu tham khảo
Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N. Engl. J. Med., 382, 727, 10.1056/NEJMoa2001017
WHO, 2020
Ruan, 2020, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med., 46, 846, 10.1007/s00134-020-05991-x
Zuo, 2020, Neutrophil extracellular traps (NETs) as markers of disease severity in COVID-19, MedRxiv
Sethuraman, 2020, Interpreting diagnostic tests for SARS-CoV-2, J. Am. Med. Assoc., 323, 2249, 10.1001/jama.2020.8259
Tay, 2020, The trinity of COVID-19: immunity, inflammation and intervention, Nat. Rev. Immunol., 20, 363, 10.1038/s41577-020-0311-8
Long, 2020, Antibody responses to SARS-CoV-2 in patients with COVID-19, Nat. Med., 10.1038/s41591-020-0897-1
Du, 2020, Mathematical modeling of interaction between innate and adaptive immune responses in COVID‐19 and implications for viral pathogenesis, J. Med. Virol., 10.1002/jmv.25866
Smatti, 2019, Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms, Viruses, 11, 762, 10.3390/v11080762
Pacheco, 2019, Bystander activation and autoimmunity, J. Autoimmun., 103, 102301, 10.1016/j.jaut.2019.06.012
Filippi, 2008, Viral trigger for type 1 diabetes: pros and cons, Diabetes, 57, 2863, 10.2337/db07-1023
Cacoub, 2014, Hepatitis C virus-induced vasculitis: therapeutic options, Ann. Rheum. Dis., 73, 24, 10.1136/annrheumdis-2013-203883
Ramos-Casals, 2005, Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases, Medicine (Baltim.), 84, 81, 10.1097/01.md.0000157397.30055.c9
Sanderson, 2017, Cocapture of cognate and bystander antigens can activate autoreactive B cells, Proc. Natl. Acad. Sci. Unit. States Am., 114, 734, 10.1073/pnas.1614472114
Chen, 2015, Correlation between systemic lupus erythematosus and cytomegalovirus infection detected by different methods, Clin. Rheumatol., 34, 691, 10.1007/s10067-015-2868-3
Dostál, 1997, Herpes viruses in multicase families with rheumatoid arthritis and systemic lupus erythematosus, Ann. N. Y. Acad. Sci., 815, 334, 10.1111/j.1749-6632.1997.tb52078.x
Wouters, 1988, Adult onset Still's disease and viral infections, Ann. Rheum. Dis., 47, 764, 10.1136/ard.47.9.764
Alberti, 2020, Guillain-Barré syndrome related to COVID-19 infection, Neurol. Neuroimmunol. Neuroinflammation., 7, e741, 10.1212/NXI.0000000000000741
Toscano, 2020, Guillain–barré syndrome associated with SARS-CoV-2, N. Engl. J. Med., 10.1056/NEJMc2009191
Virani, 2020, Guillain-Barré Syndrome associated with SARS-CoV-2 infection, IDCases, 20, 10.1016/j.idcr.2020.e00771
Coen, 2020, Guillain-Barré syndrome as a complication of SARS-CoV-2 infection, Brain Behav. Immun., 10.1016/j.bbi.2020.04.074
Scheidl, 2020, Guillain‐Barre syndrome during SARS‐CoV ‐2 pandemic: a case report and review of recent literature, J. Peripher. Nerv. Syst., 10.1111/jns.12382
Juliao Caamaño, 2020, Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2, J. Clin. Neurosci., 10.1016/j.jocn.2020.05.016
Arnaud, 2020, Post SARS-CoV-2 guillain-barré syndrome, Clin. Neurophysiol., 131, 1652, 10.1016/j.clinph.2020.05.003
Gutiérrez-Ortiz, 2020, Miller Fisher Syndrome and polyneuritis cranialis in COVID-19, Neurology, 10.1212/WNL.0000000000009619
Ottaviani, 2020, Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital, Neurol. Sci., 41, 1351, 10.1007/s10072-020-04449-8
Dinkin, 2020, COVID-19 presenting with ophthalmoparesis from cranial nerve palsy, Neurology
Zulfiqar, 2020, Immune thrombocytopenic purpura in a patient with covid-19, N. Engl. J. Med., 382, e43, 10.1056/NEJMc2010472
Lazarian, 2020, Autoimmune hemolytic anemia associated with Covid‐19 infection, Br. J. Haematol., 10.1111/bjh.16794
Lopez, 2020, Simultaneous onset of COVID‐19 and autoimmune haemolytic anaemia, Br. J. Haematol., 10.1111/bjh.16786
Murt, 2020, COVID‐19 presenting with immune thrombocytopenia: a case report and review of the literature, J. Med. Virol., 26138, 10.1002/jmv.26138
Ahmed, 2020, Thrombocytopenia as an initial manifestation of COVID‐19; case series and literature review, Br. J. Haematol., 16769
Chen, 2020, Sudden severe thrombocytopenia in a patient in the recovery stage of COVID-19, Lancet Haematol., 10.1016/S2352-3026(20)30175-7
Nathan, 2020, Atypical presentation of COVID-19 in young infants, Lancet, 395, 1481, 10.1016/S0140-6736(20)30980-6
Jones, 2020, COVID-19 and Kawasaki disease: novel virus and novel case, Hosp. Pediatr., 10.1542/hpeds.2020-0123
Riphagen, 2020, Hyperinflammatory shock in children during COVID-19 pandemic, Lancet, 395, 1607, 10.1016/S0140-6736(20)31094-1
Verdoni, 2020, An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study, Lancet, 395, 1771, 10.1016/S0140-6736(20)31103-X
Rivera-Figueroa, 2020
Belhadjer, 2020, Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic, Circulation, 10.1161/CIRCULATIONAHA.120.048360
Toubiana, 2020, Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study, BMJ, 369
Zhang, 2020, Coagulopathy and antiphospholipid antibodies in patients with covid-19, N. Engl. J. Med., 382, e38, 10.1056/NEJMc2007575
Harzallah, 2020, Lupus anticoagulant is frequent in patients with Covid‐19, J. Thromb. Haemostasis
Bowles, 2020, Lupus anticoagulant and abnormal coagulation tests in patients with covid-19, N. Engl. J. Med., 10.1056/NEJMc2013656
Helms, 2020, High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study, Intensive Care Med., 46, 1089, 10.1007/s00134-020-06062-x
Luo, 2020, Tocilizumab treatment in COVID-19: a single center experience, J. Med. Virol., 10.1002/jmv.25801
Ahn, 2020, Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19), J. Microbiol. Biotechnol., 30, 313, 10.4014/jmb.2003.03011
Cantini, 2020, Baricitinib therapy in COVID-19: a pilot study on safety and clinical impact, J. Infect., 10.1016/j.jinf.2020.04.017
McGonagle, 2006, A proposed classification of the immunological diseases, PLoS Med., 3, e297, 10.1371/journal.pmed.0030297
Doria, 2012, Autoinflammation and autoimmunity: bridging the divide, Autoimmun. Rev., 12, 22, 10.1016/j.autrev.2012.07.018
Generali, 2018, Nature versus nurture in the spectrum of rheumatic diseases: classification of spondyloarthritis as autoimmune or autoinflammatory, Autoimmun. Rev., 17, 935, 10.1016/j.autrev.2018.04.002
Caso, 2018, From autoinflammation to autoimmunity: old and recent findings, Clin. Rheumatol., 37, 2305, 10.1007/s10067-018-4209-9
Ghiringhelli, 2009, Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors, Nat. Med., 15, 1170, 10.1038/nm.2028
Kahlenberg, 2011, Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus, J. Immunol., 187, 6143, 10.4049/jimmunol.1101284
Rawlings, 2012, Integration of B cell responses through Toll-like receptors and antigen receptors, Nat. Rev. Immunol., 12, 282, 10.1038/nri3190
Sbidian, 2019, Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds, Br. J. Dermatol., 181, 1304, 10.1111/bjd.18203
2013
Wang, 2020, Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19), HLA, 10.1111/tan.13941
Ellinghaus, 2020, The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis, MedRxiv
Lokman, 2020, Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: a computational biology approach, Infect. Genet. Evol., 104389, 10.1016/j.meegid.2020.104389
Letko, 2020, Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses, Nat. Microbiol., 5, 562, 10.1038/s41564-020-0688-y
Meng-Yuan, 2020, Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues, Infect. Disease Poverty., 9, 45, 10.1186/s40249-020-00662-x
Sungnak, 2020, SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes, Nat. Med., 26, 681, 10.1038/s41591-020-0868-6
Hoffmann, 2020, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052
Zang, 2020, TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes, Sci. Immunol., 5, 10.1126/sciimmunol.abc3582
Du, 2020, Clinical features of 85 fatal cases of COVID-19 from wuhan: a retrospective observational study, Am. J. Respir. Crit. Care Med., 201, 1372, 10.1164/rccm.202003-0543OC
Zhang, 2020
Liu, 2020, Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression, Int. J. Infect. Dis., 95, 183, 10.1016/j.ijid.2020.03.013
Qin, 2020, Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in wuhan, China, Clin. Infect. Dis., 10.1093/cid/ciaa248
Zheng, 2020, Functional exhaustion of antiviral lymphocytes in COVID-19 patients, Cell. Mol. Immunol., 17, 533, 10.1038/s41423-020-0402-2
Zhou, 2020, Heightened innate immune responses in the respiratory tract of COVID-19 patients, Cell Host Microbe, 27, 883, 10.1016/j.chom.2020.04.017
Zhou, 2020, Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients, Natl. Sci. Rev.
Mazzoni, 2020, Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent, J. Clin. Invest., 10.1172/JCI138554
Blanco-Melo, 2020, Imbalanced host response to SARS-CoV-2 drives development of COVID-19, Cell, 181, 1036, 10.1016/j.cell.2020.04.026
Liu, 2020, Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury, Natl. Sci. Rev.
Del Valle, 2020, An inflammatory cytokine signature helps predict COVID-19 severity and death, MedRxiv
Diao, 2020, Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19), Front. Immunol., 11, 1, 10.3389/fimmu.2020.00827
Liu, 2020, Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients, EBioMedicine, 55, 102763, 10.1016/j.ebiom.2020.102763
Shi, 2020, Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China, MedRxiv
Yang, 2020, Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome, MedRxiv
Patterson, 2020, Disruption of the CCL5/RANTES-CCR5 pathway restores immune homeostasis and reduces plasma viral load in critical COVID-19, MedRxiv
Zhao
Mathew, 2020, Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions, BioRxiv
Channappanavar, 2017, Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology, Semin. Immunopathol., 39, 529, 10.1007/s00281-017-0629-x
Teuwen, 2020, COVID-19: the vasculature unleashed, Nat. Rev. Immunol., 1
van de Veerdonk, 2020, Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome, Elife, 9, 10.7554/eLife.57555
Schulze-Koops, 2004, Lymphopenia and autoimmune diseases, Arthritis Res. Ther., 6, 178, 10.1186/ar1208
Boyman, 2009, Homeostatic proliferation and survival of naïve and memory T cells, Eur. J. Immunol., 39, 2088, 10.1002/eji.200939444
Maeda, 2005, IL-6 blocks a discrete early step in lymphopoiesis, Blood, 106, 879, 10.1182/blood-2005-02-0456
Tan, 2020, Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study, Signal Transduct. Target. Theroy, 5, 33, 10.1038/s41392-020-0148-4
Khoruts, 2005, A causal link between lymphopenia and autoimmunity, Immunol. Lett., 98, 23, 10.1016/j.imlet.2004.10.022
Theofilopoulos, 2001, T cell homeostasis and systemic autoimmunity, J. Clin. Invest., 108, 335, 10.1172/JCI200112173
Gray, 2018, The roles of resident, central and effector memory CD4 T-cells in protective immunity following infection or vaccination, Immunology, 154, 574, 10.1111/imm.12929
Devarajan, 2013, Autoimmune effector memory T cells: the bad and the good, Immunol. Res., 57, 12, 10.1007/s12026-013-8448-1
Braun, 2020, Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors, MedRxiv
Novelli, 2019, CD44v3 and CD44v6 isoforms on T cells are able to discriminate different disease activity degrees and phenotypes in systemic lupus erythematosus patients, Lupus, 28, 621, 10.1177/0961203319838063
Croft, 2009, The significance of OX40 and OX40L to T-cell biology and immune disease, Immunol. Rev., 229, 173, 10.1111/j.1600-065X.2009.00766.x
Zhu, 2007, CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype, Blood, 109, 4882, 10.1182/blood-2006-10-043463
Xu, 2020, Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Lancet Respir. Med., 8, 420, 10.1016/S2213-2600(20)30076-X
Wang, 2020, Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia, J. Infect. Dis., 221, 1762, 10.1093/infdis/jiaa150
Liblau, 2002, Autoreactive CD8 T cells in organ-specific autoimmunity, Immunity, 17, 1, 10.1016/S1074-7613(02)00338-2
Knochelmann, 2018, When worlds collide: Th17 and Treg cells in cancer and autoimmunity, Cell. Mol. Immunol., 15, 458, 10.1038/s41423-018-0004-4
Xiong, 2020, Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients, Emerg, Microb. Infect., 9, 761
Zeng, 2020, Mortality of COVID-19 is associated with cellular immune function compared to immune function in Chinese han population, MedRxiv
Chu, 2016, Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways, J. Infect. Dis., 213, 904, 10.1093/infdis/jiv380
Wang, 2020, SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion, Cell. Mol. Immunol., 2
Thevarajan, 2020, Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19, Nat. Med., 26, 453, 10.1038/s41591-020-0819-2
Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7
Xiang, 2020, Antibody detection and dynamic characteristics in patients with COVID-19, Clin. Infect. Dis., 1
Xu, 2020, Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China, Nat. Med.
Fafi-Kremer, 2020, Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France, MedRxiv
GeurtsvanKessel, 2020, Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment, MedRxiv
Suthar, 2020, Rapid generation of neutralizing antibody responses in COVID-19 patients, Cell Rep. Med., 10.1016/j.xcrm.2020.100040
Robbiani, 2020, Convergent antibody responses to SARS-CoV-2 infection in convalescent individuals, BioRxiv
Bloch, 2020, Deployment of convalescent plasma for the prevention and treatment of COVID-19, J. Clin. Invest., 130, 2757, 10.1172/JCI138745
Seydoux, 2020, Analysis of a SARS-CoV-2 infected individual reveals development of potent neutralizing antibodies to distinct epitopes with limited somatic mutation, Immunity, 10.1016/j.immuni.2020.06.001
Liu, 2019, Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection, JCI Insight, 4, 10.1172/jci.insight.123158
Fu, 2020, Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools, Virol. Sin., 10.1007/s12250-020-00207-4
Rojas, 2020, Convalescent plasma in Covid-19: possible mechanisms of action, Autoimmun. Rev., 19, 102554, 10.1016/j.autrev.2020.102554
Joyner, 2020, Early safety indicators of COVID-19 convalescent plasma in 5,000 patients, J. Clin. Invest., 10.1172/JCI140200
Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5
Wu, 2020, TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib, J. Microbiol. Immunol. Infect., 53, 368, 10.1016/j.jmii.2020.03.005
Behrens, 2017, Review: cytokine storm syndrome: looking toward the precision medicine era, Arthritis Rheum., 69, 1135, 10.1002/art.40071
Wang, 2020, Clinical features of 69 cases with coronavirus disease 2019 in wuhan, China, Clin. Infect. Dis.
Shimabukuro-Vornhagen, 2018, Cytokine release syndrome, J. Immunother. Canc., 6, 56, 10.1186/s40425-018-0343-9
Behrens, 2019, Cytokines in cytokine storm syndrome, 197
Tanaka, 2016, Immunotherapeutic implications of IL-6 blockade for cytokine storm, Immunotherapy, 8, 959, 10.2217/imt-2016-0020
Xu, 2020, Effective treatment of severe COVID-19 patients with tocilizumab, Proc. Natl. Acad. Sci. Unit. States Am., 117, 10970, 10.1073/pnas.2005615117
Perrone, 2020, 1
Mehta, 2020, COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet, 395, 1033, 10.1016/S0140-6736(20)30628-0
Giamarellos-Bourboulis, 2020, Complex immune dysregulation in COVID-19 patients with severe respiratory failure, Cell Host Microbe, 27, 992, 10.1016/j.chom.2020.04.009
Duret, 2020, Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept, Ann. Rheum. Dis., 10.1136/annrheumdis-2020-217362
Moutsopoulos, 2020, Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19, Ann. Rheum. Dis., 10.1136/annrheumdis-2020-217562
Mihai, 2020, COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD, Ann. Rheum. Dis., 79, 668, 10.1136/annrheumdis-2020-217442
Guilpain, 2020, Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia, Ann. Rheum. Dis., 10.1136/annrheumdis-2020-217549
Sharmeen, 2020, COVID-19 in rheumatic disease patients on immunosuppressive agents, Semin. Arthritis Rheum., 10.1016/j.semarthrit.2020.05.010
Emmi, 2020, SARS-CoV-2 infection among patients with systemic autoimmune diseases, Autoimmun. Rev., 19, 102575, 10.1016/j.autrev.2020.102575
Rigamonti, 2020, Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study, Clin. Gastroenterol. Hepatol., 10.1016/j.cgh.2020.05.047
Schulert, 2014, Macrophage activation syndrome and cytokine-directed therapies, Best Pract. Res. Clin. Rheumatol., 28, 277, 10.1016/j.berh.2014.03.002
Ramos-Casals, 2014, Adult haemophagocytic syndrome, Lancet, 383, 1503, 10.1016/S0140-6736(13)61048-X
Deane, 2010, Macrophage activation syndrome in autoimmune disease, Int. Arch. Allergy Immunol., 153, 109, 10.1159/000312628
Crayne, 2019, The immunology of macrophage activation syndrome, Front. Immunol., 10, 10.3389/fimmu.2019.00119
Bin Dhuban, 2019, Signaling through gp130 compromises suppressive function in human FOXP3+ regulatory T cells, Front. Immunol., 10, 1, 10.3389/fimmu.2019.01532
O'Sullivan, 2006, IL-1β breaks tolerance through expansion of CD25 + effector T cells, J. Immunol., 176, 7278, 10.4049/jimmunol.176.12.7278
Pouchot, 2012, Biological treatment in adult-onset Still's disease, Best Pract. Res. Clin. Rheumatol., 26, 477, 10.1016/j.berh.2012.07.002
Singh, 2010, Tocilizumab for rheumatoid arthritis
Zheng, 2008, Cutting edge: foxp3 + CD4 + CD25 + regulatory T cells induced by IL-2 and TGF-β are resistant to Th17 conversion by IL-6, J. Immunol., 180, 7112, 10.4049/jimmunol.180.11.7112
Davis, 2011, The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus, J. Interferon Cytokine Res., 31, 781, 10.1089/jir.2011.0047
Li, 2020, Autoinflammatory pathogenesis and targeted therapy for adult-onset Still's disease, Clin. Rev. Allergy Immunol., 58, 71, 10.1007/s12016-019-08747-8
Chen, 2013, Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease, Arthritis Res. Ther., 15, R39, 10.1186/ar4193
Antoniou, 2013, Adult onset Still's disease: a case report with a rare clinical manifestation and pathophysiological correlations, Case Rep. Med., 1, 10.1155/2013/981232
Gerfaud-Valentin, 2014, Adult-onset Still's disease, Autoimmun. Rev., 13, 708, 10.1016/j.autrev.2014.01.058
Baggio, 2017, Gender Medicine: a interdisciplinary approach to medicine, G. Ital. Med. Lav. Ergon., 39, 196
Angela Tincani, 2018, Gender differences in rheumatology and the point of view of the Italian Society for Rheumatology (SIR), Italy J. Gender-Specific Med., 4, e79
Crosslin, 2011, Sex differences in disease severity among patients with systemic lupus erythematosus, Gend. Med., 8, 365, 10.1016/j.genm.2011.10.003
Roussou, 2011, Spondyloarthritis in women: differences in disease onset, clinical presentation, and Bath Ankylosing Spondylitis Disease Activity and Functional indices (BASDAI and BASFI) between men and women with spondyloarthritides, Clin. Rheumatol., 30, 121, 10.1007/s10067-010-1581-5
Quintero, 2012, Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity, J. Autoimmun., 38, J109, 10.1016/j.jaut.2011.10.003
Ortona, 2015, Sex hormones and gender disparity in immunity and autoimmunity, Italy J. Gender-Specifi c Med., 1, 45
Naugler, 2007, Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production, Science, 317, 121, 10.1126/science.1140485
Zhang, 2018, The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation, J. Neuroinflammation, 15, 206, 10.1186/s12974-018-1246-x
Anna Ruggieri, 2020, Gender differences in COVID-19: some open questions, Italy. J. Gender-Specific Med., 6, 49
Jin, 2020, Gender differences in patients with COVID-19: focus on severity and mortality, Front. Public. Health, 8, 152, 10.3389/fpubh.2020.00152
Cameron, 2012, Lack of innate Interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model, PloS One, 7, 10.1371/journal.pone.0045842
Bao, 2020, Reinfection could not occur in SARS-CoV-2 infected rhesus macaques, BioRxiv
Clay, 2012, Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge, J. Virol., 86, 4234, 10.1128/JVI.06791-11
Chen, 2020, Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report, Int. J. Infect. Dis., 93, 297, 10.1016/j.ijid.2020.03.003
Wu, 2007, Duration of antibody responses after severe acute respiratory syndrome, Emerg. Infect. Dis., 13, 1562, 10.3201/eid1310.070576
Gorse, 2020, Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus‐associated illnesses, J. Med. Virol., 92, 512, 10.1002/jmv.25715
2020
Atkinson, 2020, SARS-CoV-2 shedding and infectivity, Lancet, 395, 1339, 10.1016/S0140-6736(20)30868-0
Bullard, 2020, Predicting infectious SARS-CoV-2 from diagnostic samples, Clin. Infect. Dis., 10.1093/cid/ciaa638
Lucchese, 2020, Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons, Autoimmun. Rev., 19, 102556, 10.1016/j.autrev.2020.102556
Kanduc, 2020, On the molecular determinants of the SARS-CoV-2 attack, Clin. Immunol., 215, 108426, 10.1016/j.clim.2020.108426
Vojdani, 2020, Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases, Clin. Immunol., 217, 108480, 10.1016/j.clim.2020.108480
Aguiar, 2013, Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease, Ther. Adv. Musculoskelet. Disease, 5, 305, 10.1177/1759720X13502919
Raucci, 2020, Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms, Autoimmun. Rev., 19, 102572, 10.1016/j.autrev.2020.102572
Galván Casas, 2020, Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases, Br. J. Dermatol., 10.1111/bjd.19163
Shamsizadeh, 2014, Clinical and epidemiological characteristics of Kawasaki disease, Jundishapur J. Microbiol., 7, 10.5812/jjm.11014
Fernandez-Cooke, 2019, Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011-2016): KAWA-RACE study group, PloS One, 14, 10.1371/journal.pone.0215665
Matsubara, 2005, Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease, Clin. Exp. Immunol., 141, 381, 10.1111/j.1365-2249.2005.02821.x
Franco, 2010, Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease, Autoimmunity, 43, 317, 10.3109/08916930903405891
Rowley, 2011, Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a “new” virus associated with Kawasaki disease, J. Infect. Dis., 203, 1021, 10.1093/infdis/jiq136
Son, 2020, Pediatric inflammatory syndrome temporally related to covid-19, BMJ, 369, m2123, 10.1136/bmj.m2123
Rodríguez, 2018, Guillain–Barré syndrome, transverse myelitis and infectious diseases, Cell. Mol. Immunol., 15, 547, 10.1038/cmi.2017.142
Baig, 2020, Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms, ACS Chem. Neurosci., 11, 995, 10.1021/acschemneuro.0c00122
Costello, 2020, Cranial neuropathies and COVID-19: neurotropism and autoimmunity, Neurology, 10.1212/WNL.0000000000009921
Ferro F, 2020, COVID-19: the new challenge for rheumatologists, Clin. Exp. Rheumatol., 38, 373
Touret, 2020, Of chloroquine and COVID-19, Antivir. Res., 177, 104762, 10.1016/j.antiviral.2020.104762
Sarzi-Puttini, 2020, COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?, Clin. Exp. Rheumatol., 38, 337, 10.55563/clinexprheumatol/xcdary
Ceribelli, 2020, Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy, J. Autoimmun., 109, 102442, 10.1016/j.jaut.2020.102442